BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38556548)

  • 21. Transcriptome changes during the initiation and progression of Duchenne muscular dystrophy in Caenorhabditis elegans.
    Hrach HC; O'Brien S; Steber HS; Newbern J; Rawls A; Mangone M
    Hum Mol Genet; 2020 Jun; 29(10):1607-1623. PubMed ID: 32227114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.
    Laurila PP; Luan P; Wohlwend M; Zanou N; Crisol B; Imamura de Lima T; Goeminne LJE; Gallart-Ayala H; Shong M; Ivanisevic J; Place N; Auwerx J
    Sci Adv; 2022 Jan; 8(4):eabh4423. PubMed ID: 35089797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
    González-Sánchez J; Sánchez-Temprano A; Cid-Díaz T; Pabst-Fernández R; Mosteiro CS; Gallego R; Nogueiras R; Casabiell X; Butler-Browne GS; Mouly V; Relova JL; Pazos Y; Camiña JP
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1063-1078. PubMed ID: 30216693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy.
    Hayashiji N; Yuasa S; Miyagoe-Suzuki Y; Hara M; Ito N; Hashimoto H; Kusumoto D; Seki T; Tohyama S; Kodaira M; Kunitomi A; Kashimura S; Takei M; Saito Y; Okata S; Egashira T; Endo J; Sasaoka T; Takeda S; Fukuda K
    Nat Commun; 2015 Apr; 6():6745. PubMed ID: 25865621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxandrolone enhances skeletal muscle myosin synthesis and alters global gene expression profile in Duchenne muscular dystrophy.
    Balagopal P; Olney R; Darmaun D; Mougey E; Dokler M; Sieck G; Hammond D
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E530-9. PubMed ID: 16263771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy.
    Péladeau C; Jasmin BJ
    Methods Mol Biol; 2023; 2587():495-510. PubMed ID: 36401046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy.
    Gao Z; Lu A; Daquinag AC; Yu Y; Huard M; Tseng C; Gao X; Huard J; Kolonin MG
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and phenotypic analysis of rodent models reveals conserved and species-specific modulators of human sarcopenia.
    Börsch A; Ham DJ; Mittal N; Tintignac LA; Migliavacca E; Feige JN; Rüegg MA; Zavolan M
    Commun Biol; 2021 Feb; 4(1):194. PubMed ID: 33580198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model.
    Shi S; Hoogaars WM; de Gorter DJ; van Heiningen SH; Lin HY; Hong CC; Kemaladewi DU; Aartsma-Rus A; ten Dijke P; 't Hoen PA
    Neurobiol Dis; 2011 Feb; 41(2):353-60. PubMed ID: 20940052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Belosludtseva NV; Belosludtsev KN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
    Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
    Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligonol Alleviates Sarcopenia by Regulation of Signaling Pathways Involved in Protein Turnover and Mitochondrial Quality.
    Chang YC; Chen YT; Liu HW; Chan YC; Liu MY; Hu SH; Tseng WT; Wu HL; Wang MF; Chang SJ
    Mol Nutr Food Res; 2019 May; 63(10):e1801102. PubMed ID: 30793867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IP
    Valladares D; Utreras-Mendoza Y; Campos C; Morales C; Diaz-Vegas A; Contreras-Ferrat A; Westermeier F; Jaimovich E; Marchi S; Pinton P; Lavandero S
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3685-3695. PubMed ID: 30251688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.
    Krishnan SM; Nordlohne J; Dietz L; Vakalopoulos A; Haning P; Hartmann E; Seifert R; Hüser J; Mathar I; Sandner P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.
    Oliveira-Santos A; Dagda M; Burkin DJ
    Hum Mol Genet; 2022 Jul; 31(14):2358-2369. PubMed ID: 35157045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mimicking sarcolemmal damage
    Tejedera-Villafranca A; Montolio M; Ramón-Azcón J; Fernández-Costa JM
    Biofabrication; 2023 Sep; 15(4):. PubMed ID: 37725998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.